Latest News

Male alopecia agents ranked by efficacy in meta-analysis


 

FROM JAMA DERMATOLOGY

Adverse event considerations important

Importantly, however, strong consideration needs to be given to adverse-event profiles, as well as patient comorbidities in selecting agents, the editorial authors asserted.

With 1 mg finasteride, for instance, potential adverse events include decreased libido, erectile dysfunction, decreased ejaculatory volume, reduction in sperm count, testicular pain, depression, and gynecomastia, they noted.

And while finasteride appears to be associated with a decreased risk of prostate cancer, those receiving the drug who do develop prostate cancer may be diagnosed with higher-grade prostate cancer; however, that “might be related to tissue sampling artifact,” the editorial authors said.

Less has been published on dutasteride’s adverse-event profile, and that, in itself, is a concern.

Antonella Tosti, MD, Fredric Brandt Endowed Professor of Dermatology and Cutaneous Surgery at the University of Miami, Miami, Florida Dr. Antonella Tosti

Dr. Antonella Tosti

Overall, “as more direct-to-consumer companies treating male AGA emerge, it is especially important that the potential risks of these medications be made clear to patients,” they added.

Further commenting on the analysis to this news organization, Antonella Tosti, MD, the Fredric Brandt Endowed Professor of Dermatology and Cutaneous Surgery at the University of Miami, said the study offers some important insights – and caveats.

“I think this is a very interesting study, but you have to consider what works for your patients,” she said.

Dr. Tosti noted that the 5-mg dose of minoxidil is a concern in terms of side effects. “That dose is pretty high and could feasibly cause some hypertrichosis, which can be a concern to men as well as women.”

She agrees that the lack of data on side effects with dutasteride is also a concern, especially in light of some of the known side effects with other agents.

“That’s why I don’t use it very much in younger patients – because I’m afraid it could potentially affect their fertility,” Dr. Tosti said.

In general, Dr. Tosti said she finds a combination of agents provides the best results, as many clinicians use.

“I find dutasteride (0.5 mg/day) plus oral minoxidil (1-2.5 mg/day) plus topical 5% minoxidil is the best combination,” she said.

The authors and Dr. Tosti disclosed no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

High-Dose Finasteride Halts Hair Loss in Women
MDedge Endocrinology
FDA issues strong warning about oral ketoconazole
MDedge Endocrinology
Turn down the androgens to treat female pattern hair loss
MDedge Endocrinology
EADV: Hidradenitis suppurativa carries high cardiovascular risk
MDedge Endocrinology
Do black women pay a price for hair care regimens?
MDedge Endocrinology
Hormone use linked to hair loss in transgender adults
MDedge Endocrinology
Evidence on spironolactone safety, COVID-19 reassuring for acne patients
MDedge Endocrinology
Increased risk of meningioma with cyproterone acetate use
MDedge Endocrinology
Gray hair goes away and squids go to space
MDedge Endocrinology
New finasteride lawsuit brings renewed attention to psychiatric, ED adverse event reports
MDedge Endocrinology